OVID THERAPEUTICS INC.Stock Option Agreement • February 3rd, 2017 • Ovid Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 3rd, 2017 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (the “Option Agreement”).
OVID THERAPEUTICS INC.Stock Option Agreement • February 3rd, 2017 • Ovid Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 3rd, 2017 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement — Early Exercise (the “Option Agreement”).
OVID THERAPEUTICS INC.Restricted Stock Purchase Agreement • February 3rd, 2017 • Ovid Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 3rd, 2017 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Restricted Stock Purchase Agreement (the “Agreement”).
SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • February 3rd, 2017 • Ovid Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 3rd, 2017 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 6th day of January, 2017, by and among Ovid Therapeutics Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder.”